Home / Olmesartan Medoxomil and Diuretics / Canada
CA ATC C09DA08 · updated 2 Nov 2026
Olmesartan Medoxomil and Diuretics shortage in Canada
Is there an Olmesartan Medoxomil and Diuretics shortage in Canada?
Yes. As of 2 Nov 2026, 7 Olmesartan Medoxomil and Diuretics products are reported short in Canada, the first since 15 Sep 2024. The company estimate for the return is 27 Nov 2026 (latest 31 Mar 2027). Main reason: manufacturing problem.
Also short in Italy, Spain, Belgium. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO-OLMESARTAN/HCTZ (90 BTL) | APOTEX INC | 15 Sep 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-OLMESARTAN/HCTZ (90 BTL) | APOTEX INC | 12 Nov 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-OLMESARTAN/HCTZ (90 BTL) | APOTEX INC | 12 Nov 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NRA-OLMESARTAN HCTZ (Blister 30, Bottle 90) | NORA PHARMA INC | 16 Dec 2024 | 31 Mar 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NRA-OLMESARTAN HCTZ (Blister 30, Bottle 90) | NORA PHARMA INC | 10 Feb 2025 | 31 Mar 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NRA-OLMESARTAN HCTZ (Blister 30, Bottle 90) | NORA PHARMA INC | 10 Feb 2025 | 31 Mar 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | GLN-OLMESARTAN HCTZ (30's) | GLENMARK PHARMACEUTICALS CANADA INC. | 29 Oct 2026 | 27 Nov 2026 | Increased demand Demand increase for the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.